ABSA International
ABSA International

Resources with keywords: covid-19



CDC's Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings (Website, Regulatory)
CDC
12 April 2024
Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2 (Website, Regulatory)
CDC
18 March 2024

In general, asymptomatic healthcare personnel (HCP) who have had a higher-risk exposure do not require work restriction, regardless of vaccination status, if they do not develop symptoms or test positive for SARS-CoV-2.

Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 (NEW 4/3, Website, Regulatory)
WHO
11 March 2024

The latest update (11 March 2024) includes the following addition and revision:

  • depending on the local risk assessment, less stringent risk control measures for virus isolation and propagation of currently circulating strains;
  • biosafety aspects of waste management;
  • detailed considerations for transportation requirements; and
  • reference to the 4th edition Laboratory biosafety manual for GMPP (good microbiological practice and procedure) and to the Risk assessment monograph for the risk assessment template.
Laboratory biosafety guidance related to SARS-CoV-2 (COVID-19): Interim guidance, 11 March 2024 (NEW 5/10, Website, Regulatory)
World Health Organization (WHO)
11 March 2024

Provides interim guidance on laboratory biosafety related to the SARS-CoV-2 virus to laboratories and stakeholders involved in COVID-19 laboratory work. This also includes the packaging and shipment requirements for sending specimens to WHO reference laboratories providing confirmatory and other testing for COVID-19.

At-Home OTC COVID-19 Diagnostic Tests (Website)
FDA

Includes information on various tests, who can use, and extended expiration dating for some tests.

Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care Facilities, Kentucky, USA, 2021–2022 (NEW 4/3, Website, Publication)
CDCD / Emerging Infectious Diseases
1 March 2024

Keck JW, Adatorwovor R, Liversedge M, et al.
Persons living in long-term care facilities (LTCFs) were disproportionately affected by COVID-19. We used wastewater surveillance to detect SARS-CoV-2 infection in this setting by collecting and testing 24-hour composite wastewater samples 2–4 times weekly at 6 LTCFs in Kentucky, USA, during March 2021–February 2022.

CDC updates and simplifies respiratory virus recommendations (Website)
CDC
1 March 2024

CDC released updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. The new guidance brings a unified approach to addressing risks from a range of common respiratory viral illnesses, such as COVID-19, flu, and RSV.

COVID-19 Vaccine Effectiveness (Website)
CDC / National Center for Immunization and Respiratory Diseases (NCIRD)
1 February 2024

CDC says that updated (2023-2024) COVID-19 vaccines were effective against COVID-19 during September 2023 – January 2024, including against variants from the XBB lineage, which is included in the updated vaccine, and JN.1, a new variant that has become dominant in recent weeks.

Urgent Need to Increase Immunization Coverage for Influenza, COVID-19, and RSV and Use of Authorized/Approved Therapeutics in the Setting of Increased Respiratory Disease Activity During the 2023 – 2024 Winter Season
CDC/Health Alert Network (HAN)
Protect yourself and others from Flu, COVID-19, and RSV
CDC

CDC’s new page has county-level information on how Flu, COVID-19 and RSV viruses are trending in your area, and other useful info.

Go to Top